Contact
We publish what the research supports.
MaxHuman covers peptides and longevity compounds for readers who want to know what the evidence establishes before they act on it.
Most writing about peptides has a commercial reason to reach a conclusion. Vendor sites need the compound to work. Affiliate guides need you to click through. The result is a body of content where confident dosing numbers circulate for years without anyone able to point to where they came from.
We are not selling the compounds we write about. That means we can publish the finding that a substance has no human trials at all, which is frequently the most useful thing a reader can learn.
How an article gets made
Every factual claim in an article is checked against the primary literature before it is written, not after. The process is deliberately mechanical:
1.
Claims are listed first. Before drafting, each assertion the article intends to make is written out as a separate, checkable statement.
2.
Each claim is searched independently across Europe PMC, PubMed and Crossref.
3.
A source either supports the claim or it does not. Topical adjacency is not support. A paper about a related compound does not back a statement about this one.
4.
Claims that only partly hold up are rewritten to the weaker version the study genuinely supports, and the article uses that wording.
5.
Claims with no support are dropped. The article says plainly what it could not establish.
That last step is the one that matters. An article which quietly omits what it failed to verify looks identical to one that verified everything. We would rather tell you which questions we could not answer.
Who writes and reviews
Victor Björk
Uppsala University · Molecular Biology · Longevity Biotech
Works as an independent longevity consultant. He checks our articles for scientific accuracy before publication.